Maria Teresa Pesce
A5051072688- Global Cancer Incidence and Screening
- Cervical Cancer and HPV Research
- Cancer Risks and Factors
- Cancer Genomics and Diagnostics
- Colorectal Cancer Screening and Detection
- Nutritional Studies and Diet
- Lung Cancer Research Studies
- AI in cancer detection
- Palliative Care and End-of-Life Issues
- BRCA gene mutations in cancer
- Genital Health and Disease
- Breast Cancer Treatment Studies
- Neuroendocrine Tumor Research Advances
- Economic and Financial Impacts of Cancer
- Neuroblastoma Research and Treatments
- Breast Implant and Reconstruction
- Endometrial and Cervical Cancer Treatments
- Genetic factors in colorectal cancer
- Multiple and Secondary Primary Cancers
•Italy will have 4 million cancer survivors in 2030 (6.9% of the population), half diagnosed at least 10 years earlier.•From 2018 to 2030, complete prevalence increase by 1.5% per year.•As many as 7 out 8 prevalent cases same life expectancy general population.•Ten after diagnosis, 96% not die from cancer.•Prevalence estimates are essential improve consistent, data-driven control planning. BackgroundThe number and projections necessary meet healthcare needs patients, while data on cure...
Background: The increasing incidence, rapidly evolving classification, rarity and heterogeneity of neuroendocrine neoplasms (NENs) pose challenges to NEN registration including difficulty in distinguishing carcinoma (NEC) tumours (NETs). Thus, Italy a higher NEC incidence was reported. Focusing on gastroenteropancreatic (GEP) NEN, we aimed review GEP particular cases carcinoma, not otherwise specified (NOS) estimate the NET GEP. Methods We launched pilot study examining carcinomas NOS...
Background/Objectives: The increasing incidence of cancer during pregnancy is a growing public health concern, driven by delayed parenthood and rising maternal age. Pregnancy-associated (PAC) presents complex clinical challenges, necessitating balance between treatment fetal safety. Historically considered incompatible with favorable outcomes, evidence now suggests that can often proceed without affecting prognosis. A 2022 study in Italy provided the first population-based PAC estimates...
To describe the procedures to derive complete prevalence and several indicators of cancer cure from population-based registries. Cancer registry data (47% Italian population) were used calculate limited duration for 62 types by sex registry. The incidence survival models, needed completeness index (R) prevalence, evaluated likelihood ratio tests visual comparison. A sensitivity analysis was conducted explore effect on using different R indexes. Mixture models estimate net (NS); life...
Abstract People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are increasing. This paper aimed to estimate the indicators of cure and complete prevalence for Italian patients with BC CRC by stage age. A total 31 Cancer Registries (47% population) data until 2017 were included. Mixture models allowed estimation net survival (NS); fraction (CF); time (TTC, 5‐year conditional NS >95%); (who will not die cancer); already cured (prevalent living longer than TTC). 2.6%...
Objective: To evaluate short-term (2008–2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and type. Methods: Observational study from population-based data collected 20 Italian Cancer Registries, covering 33% of the population. The age-standardized rates (ASRs), overall stratified area, sex, site or type, major age groups (i.e., 20-39, 40-49), were computed. Results: In 2008-2017, almost two times higher women than age-corresponding men (202.2 vs 112.4 per...
Purpose The aim of this study was to compare the functional characteristics two computer-based systems for quality control cancer registry data through analysis their output differences. Methods used incidence from 22 49 registries Italian Network Cancer Registries registered between 1986 and 2017. Two different checking developed by WHO International Agency Research on (IARC) Joint Center (JRC) with European (ENCR) routinely registrars were check data. outputs generated same dataset each...
Objective: Five-year net survival and conditional from vulvar squamous cell carcinoma (VSCC) in Italy have shown no progress during the past three decades. This study aims to estimate complete prevalence multiple indicators of cure for VSCC patients.Methods: Thirty-one population-based cancer registries covering 47% Italian female population provided data 8,070 incident (1978-2017) cases (83% aged ≥65 years). Mixture models were used several patients. Results: In 2018, patients alive...